Asabys Partners

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€75m

Latest public closing

19 May 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Barcelona-based venture capital firm investing in healthcare innovation and life-sciences companies.

Focus: Human healthcare, especially biopharma and health tech, including medtech and digital health

26 September 2024: Sabadell Asabys Health Innovation Investments II closed oversubscribed at €180m, above its €150m target; in May 2026 it launched a technology-transfer fund of up to €120m (company announcements).